What is the recommended treatment for croup in the emergency room (ER)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Croup in the Emergency Room

For all patients with croup presenting to the emergency room, a single dose of dexamethasone (0.15-0.60 mg/kg orally) is recommended, regardless of disease severity, with nebulized epinephrine (0.5 ml/kg of 1:1000 solution) added for moderate to severe cases. 1

Assessment of Croup Severity

The Westley Croup Score should be used to assess severity:

Parameter 0 points 1 point 2 points 3 points 4 points 5 points
Stridor None When agitated At rest - - -
Retractions None Mild Moderate Severe - -
Air entry Normal Decreased Markedly decreased - - -
Cyanosis None - - With agitation At rest -
Level of consciousness Normal - - - - Altered

Severity classification:

  • Mild: Score 0-2
  • Moderate: Score 3-5
  • Severe: Score 6-11
  • Impending respiratory failure: Score ≥12

Treatment Algorithm

For All Patients with Croup

  • Dexamethasone 0.15-0.60 mg/kg orally as a single dose (maximum 10-12 mg) 1, 2
    • This is supported by high-quality evidence from the American Academy of Pediatrics and American Thoracic Society
    • Lower doses (0.15 mg/kg) have been shown to be as effective as higher doses (0.6 mg/kg) for moderate to severe croup 3
    • For patients unable to tolerate oral medication due to vomiting or severe respiratory distress, use intramuscular dexamethasone at the same dosage 4, 5

For Moderate to Severe Croup (Score ≥3)

  • Add nebulized epinephrine (0.5 ml/kg of 1:1000 solution) 1
  • Monitor for at least 2-3 hours after nebulized epinephrine administration to observe for potential rebound symptoms
  • Continuous oxygen saturation monitoring is required
  • Reassess croup score 15-30 minutes after initial treatment and regularly thereafter

Supportive Care

  • Maintain a calm environment
  • Position the child in a comfortable position (often upright or in parent's arms)
  • Ensure adequate hydration
  • Provide supplemental oxygen if saturation is <92%
  • Closely monitor respiratory rate, work of breathing, and oxygen saturation

Admission Criteria

Consider hospital admission if any of the following are present:

  • Oxygen saturation <92% or cyanosis
  • Persistent significant respiratory distress after treatment
  • Stridor at rest that persists after treatment
  • Need for more than one dose of nebulized epinephrine
  • Inability to tolerate oral fluids
  • Toxic appearance

Discharge Criteria

Patients can be discharged if:

  • Significant improvement in symptoms
  • Able to tolerate oral fluids
  • No repeated doses of epinephrine required
  • Follow-up should be arranged within 48 hours if symptoms persist

Important Caveats and Pitfalls

  1. Avoid routine imaging unless there is suspicion of an alternative diagnosis or failure to respond to standard therapy 1

  2. Avoid nebulized epinephrine for children who will be discharged shortly, as the effect is short-lived (1-2 hours) and rebound symptoms may occur 1

  3. Consider alternative diagnoses if not responding to standard therapy, including:

    • Bacterial tracheitis
    • Epiglottitis
    • Foreign body aspiration
    • Peritonsillar abscess
    • Retropharyngeal abscess
    • Angioedema 2
  4. Humidification therapy has not been proven beneficial in the treatment of croup 2

  5. Risk of corticosteroid complications is rare, making dexamethasone a safe and effective treatment option 4, 6

  6. Be vigilant for signs of deterioration including increased work of breathing, lethargy, or cyanosis, which may indicate need for escalation of care 1

References

Guideline

Pediatric Scoring Systems for Illness Severity

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Croup: an overview.

American family physician, 2011

Research

The role of corticosteroids in the treatment of croup.

Treatments in respiratory medicine, 2004

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.